.JPG?ad=18503&adview=true)
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Chemoprevention Branch, Cancer Prevention Research Program, Division of Cancer Prevention and Control, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892
A search of the literature using National Library of Medicine databases and individual cancer journal articles yielded over 500 compounds with published chemopreventive activity in animals. From these, an initial 16 agents or agent combinations have been evaluated in the following animal tumor models: mouse skin papillomas/carcinomas induced by 7,12-dimethylbenz(a)anthracene/12-O-tetradecanoylphorbol-13-acetate; rat breast adenocarcinoma induced by N-methyl-N-nitrosourea or 7,12-dimethylbenz(a)anthracene; hamster lung carcinoma induced by N-methyl-N-nitrosourea or diethylnitrosamine; mouse bladder papillary carcinoma induced by N-butyl-N-(4-hydroxybutyl)nitrosamine; and rat and mouse colon cancer induced by azoxymethane/methylazoxymethanol acetate. Some of the most interesting positive results observed include 4-hydroxyphenyl retinamide plus tamoxifen in breast cancer, piroxicam in colon cancer, dimethylfluoroornithine in breast and bladder cancer, oltipraz in lung cancer, dehydroepiandrosterone in colon cancer, and molybdate in bladder cancer. Eighteen human intervention trials in progress are described that involve the following agents: ß-carotene (eight trials). Retinol/retinoic acid (seven trials), vitamins C and E (three trials), 4-hydroxyphenyl retinamide (one trial), piroxicam (one trial), and calcium (one trial). By organ site these studies involve cancer of the lung (six studies), skin (five studies), colon (four studies), breast (one study), and uterine cervix (two studies).
1 To whom requests for reprints should be addressed, at Chemoprevention Branch, CPRP, DCPC, National Cancer Institute, NIH, 9000 Rockville Pike, Bethesda, MD 20892-4200.
Received 9/16/88. Revised 5/10/89. Revised 9/19/89. Accepted 10/ 2/89.
This article has been cited by other articles:
|
|
 |
|
  A Mizote, Y Okazaki, M Iqbal, and S Okada Antioxidant biofactor, a processed grain food, inhibits iron nitrilotriacetate-induced renal tumorigenesis, hyperproliferative response, and oxidative damage Human and Experimental Toxicology, March 1, 2008; 27(3): 207 - 214. [Abstract] [PDF]
|
|
|
|
 |
|
 V. Khurana, H. R. Bejjanki, G. Caldito, and M. W. Owens Statins Reduce the Risk of Lung Cancer in Humans: A Large Case-Control Study of US Veterans Chest, May 1, 2007; 131(5): 1282 - 1288. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Fu, J. Xue, Z. Li, X. Shi, B.-H. Jiang, and J. Fang Chrysin inhibits expression of hypoxia-inducible factor-1{alpha} through reducing hypoxia-inducible factor-1{alpha} stability and inhibiting its protein synthesis Mol. Cancer Ther., January 1, 2007; 6(1): 220 - 226. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Sharma, P. Gao, and V. E. Steele The chemopreventive efficacy of inhaled oltipraz particulates in the B[a]P-induced A/J mouse lung adenoma model Carcinogenesis, August 1, 2006; 27(8): 1721 - 1727. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. B. Thomas and J. L. Abbruzzese Opportunities for Targeted Therapies in Hepatocellular Carcinoma J. Clin. Oncol., November 1, 2005; 23(31): 8093 - 8108. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Fang, C. Xia, Z. Cao, J. Z. Zheng, E. Reed, and B.-H. Jiang Apigenin inhibits VEGF and HIF-1 expression via PI3K/AKT/p70S6K1 and HDM2/p53 pathways FASEB J, March 1, 2005; 19(3): 342 - 353. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Tseng, E. A. Scott-Ramsay, and M. E. Morris Dietary Organic Isothiocyanates Are Cytotoxic in Human Breast Cancer MCF-7 and Mammary Epithelial MCF-12A Cell Lines Experimental Biology and Medicine, September 1, 2004; 229(8): 835 - 842. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Catalina, L. Milewich, V. Kumar, and M. Bennett Dietary Dehydroepiandrosterone Inhibits Bone Marrow and Leukemia Cell Transplants: Role of Food Restriction Experimental Biology and Medicine, December 1, 2003; 228(11): 1303 - 1320. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Vucenik and A. M. Shamsuddin Cancer Inhibition by Inositol Hexaphosphate (IP6) and Inositol: From Laboratory to Clinic J. Nutr., November 1, 2003; 133(11): 3778S - 3784. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Auyeung, F. K. Kessler, and J. K. Ritter Mechanism of Rat UDP-Glucuronosyltransferase 1A6 Induction by Oltipraz: Evidence for a Contribution of the Aryl Hydrocarbon Receptor Pathway Mol. Pharmacol., January 1, 2003; 63(1): 119 - 127. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. de Jong, I. M. Nolte, G. J. te Meerman, W. T. A. van der Graaf, E. G. E. de Vries, R. H. Sijmons, R. M. W. Hofstra, and J. H. Kleibeuker Low-penetrance Genes and Their Involvement in Colorectal Cancer Susceptibility Cancer Epidemiol. Biomarkers Prev., November 1, 2002; 11(11): 1332 - 1352. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Le Ferrec, D. Lagadic-Gossmann, C. Rauch, C. Bardiau, K. Maheo, F. Massiere, M. Le Vee, A. Guillouzo, and F. Morel Transcriptional Induction of CYP1A1 by Oltipraz in Human Caco-2 Cells Is Aryl Hydrocarbon Receptor- and Calcium-dependent J. Biol. Chem., June 28, 2002; 277(27): 24780 - 24787. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Chinni and F. H. Sarkar Akt Inactivation Is a Key Event in Indole-3-carbinol-induced Apoptosis in PC-3 Cells Clin. Cancer Res., April 1, 2002; 8(4): 1228 - 1236. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Koesters, M. A. Hans, A. Benner, R. Prosst, J. Boehm, J. Gahlen, and M. von Knebel Doeberitz Predominant mutation of codon 41 of the {beta}-catenin proto-oncogene in rat colon tumors induced by 1,2-dimethylhydrazine using a complete carcinogenic protocol Carcinogenesis, November 1, 2001; 22(11): 1885 - 1890. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. T. Sanderson, L. Slobbe, G. W. A. Lansbergen, S. Safe, and M. van den Berg 2,3,7,8-Tetrachlorodibenzo-p-dioxin and Diindolylmethanes Differentially Induce Cytochrome P450 1A1, 1B1, and 19 in H295R Human Adrenocortical Carcinoma Cells Toxicol. Sci., May 1, 2001; 61(1): 40 - 48. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Kim, D. M. Shin, A. El-Naggar, J. S. Lee, C. Corrales, S. M. Lippman, W. K. Hong, and W. N. Hittelman Chromosome Polysomy and Histological Characteristics in Oral Premalignant Lesions Cancer Epidemiol. Biomarkers Prev., April 1, 2001; 10(4): 319 - 325. [Abstract] [Full Text]
|
|
|
|
|
|
E. Le Ferrec, G. Ilyin, K. Maheo, C. Bardiau, A. Courtois, A. Guillouzo, and F. Morel Differential effects of oltipraz on CYP1A and CYP2B in rat lung Carcinogenesis, January 1, 2001; 22(1): 49 - 55. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. S. Alberts, R. T. Dorr, J. G. Einspahr, M. Aickin, K. Saboda, M. J. Xu, Y.-M. Peng, R. Goldman, J. A. Foote, J. A. Warneke, et al. Chemoprevention of Human Actinic Keratoses by Topical 2-(Difluoromethyl)-dl-ornithine Cancer Epidemiol. Biomarkers Prev., December 1, 2000; 9(12): 1281 - 1286. [Abstract] [Full Text]
|
|
|
|
|
|
A. B. Benson III, O. I. Olopade, M. J. Ratain, A. Rademaker, S. Mobarhan, L. Stucky-Marshall, S. French, and M. E. Dolan Chronic Daily Low Dose of 4-Methyl-5-(2-pyrazinyl)-1,2-dithiole-3-thione (Oltipraz) in Patients with Previously Resected Colon Polyps and First-Degree Female Relatives of Breast Cancer Patients Clin. Cancer Res., October 1, 2000; 6(10): 3870 - 3877. [Abstract] [Full Text]
|
|
|
|
 |
|
 D. L. Gustafson, H. R. Franz, A. M. Ueno, C. J. Smith, D. J. Doolittle, and C. A. Waldren Vanillin (3-methoxy-4-hydroxybenzaldehyde) inhibits mutation induced by hydrogen peroxide, N-methyl-N-nitrosoguanidine and mitomycin C but not 137Cs {gamma}-radiation at the CD59 locus in human-hamster hybrid AL cells Mutagenesis, May 1, 2000; 15(3): 207 - 213. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. August, J. Landau, D. Caputo, J. Hong, M.-J. Lee, and C. S. Yang Ingestion of Green Tea Rapidly Decreases Prostaglandin E2 Levels in Rectal Mucosa in Humans Cancer Epidemiol. Biomarkers Prev., August 1, 1999; 8(8): 709 - 713. [Abstract] [Full Text]
|
|
|
|
|
|
H. S. Kim, S. Kacew, and B. M. Lee In vitro chemopreventive effects of plant polysaccharides (Aloe barbadensis Miller, Lentinus edodes, Ganoderma lucidum and Coriolus versicolor) Carcinogenesis, August 1, 1999; 20(8): 1637 - 1640. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Dhawan, S. Balasubramanian, A. J. Amonkar, and N. Singh Chemopreventive effect of 4'-demethyl epipodophyllotoxin on DMBA/TPA-induced mouse skin carcinogenesis Carcinogenesis, June 1, 1999; 20(6): 997 - 1003. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. E. Steele, C. A. Holmes, E. T. Hawk, L. Kopelovich, R. A. Lubet, J. A. Crowell, C. C. Sigman, and G. J. Kelloff Lipoxygenase Inhibitors as Potential Cancer Chemopreventives Cancer Epidemiol. Biomarkers Prev., May 1, 1999; 8(5): 467 - 483. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. A. Münzel, S. Schmohl, H. Heel, K. Kälberer, B. S. Bock-Hennig, and K. W. Bock Induction of Human UDP Glucuronosyltransferases (UGT1A6, UGT1A9, and UGT2B7) by t-Butylhydroquinone and 2,3,7,8-Tetrachlorodibenzo-p-Dioxin in Caco-2 Cells Drug Metab. Dispos., May 1, 1999; 27(5): 569 - 573. [Abstract] [Full Text]
|
|
|
|
|
|
M. Welfare, A. M. Adeokun, M. F. Bassendine, and A. K. Daly Polymorphisms in GSTP1, GSTM1, and GSTT1 and Susceptibility to Colorectal Cancer1 Cancer Epidemiol. Biomarkers Prev., April 1, 1999; 8(4): 289 - 292. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-H. Pan, T.-M. Huang, and J.-K. Lin Biotransformation of Curcumin Through Reduction and Glucuronidation in Mice Drug Metab. Dispos., April 1, 1999; 27(4): 486 - 494. [Abstract] [Full Text]
|
|
|
|
|
|
Y. Zheng, P. M. Kramer, R. A. Lubet, V. E. Steele, G. J. Kelloff, and M. A. Pereira Effect of retinoids on AOM-induced colon cancer in rats: modulation of cell proliferation, apoptosis and aberrant crypt foci Carcinogenesis, February 1, 1999; 20(2): 255 - 260. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Muto, H. Moriwaki, M. Ninomiya, S. Adachi, A. Saito, K. T. Takasaki, T. Tanaka, K. Tsurumi, M. Okuno, E. Tomita, et al. Prevention of Second Primary Tumors by an Acyclic Retinoid, Polyprenoic Acid, in Patients with Hepatocellular Carcinoma N. Engl. J. Med., June 13, 1996; 334(24): 1561 - 1568. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. A. Rosenberg, J. E. Dencoff, N. Correa Jr., M. Reiners, and C. C. Ford Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: Relation to blood-brain barrier injury Neurology, June 1, 1996; 46(6): 1626 - 1632. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
